Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

GI-6207

Generic Name: GI-6207

Drug Type: Biotech

Unique Ingredient Identifier: FIJ3OLQ3N8

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

QUILT-3.088: NANT Pancreatic Cancer Vaccine

Phase 2

Withdrawn

Posted: 2018/06/20

Sponsor:ImmunityBio, Inc.

ID:NCT03563144

QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine

Phase 1

Terminated

Posted: 2018/06/20

Sponsor:ImmunityBio, Inc.

ID:NCT03563157

QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine

Phase 2

Withdrawn

Posted: 2018/06/12

Sponsor:ImmunityBio, Inc.

ID:NCT03554109

QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

Phase 1

Withdrawn

Posted: 2017/06/23

Sponsor:ImmunityBio, Inc.

ID:NCT03197571

QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy

Phase 1

Withdrawn

Posted: 2017/06/05

Sponsor:ImmunityBio, Inc.

ID:NCT03175666

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy